ANAB position history
The shares of Anaptysbio (ANAB) that Palo Alto Investors LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 436,592 shares, $12M, 0.71% of portfolio
- 2021 Q4: 436,592 shares, $15M, 0.97% of portfolio
- 2022 Q1: 431,024 shares, $11M, 0.82% of portfolio, Reduce −1.3%
- 2022 Q2: 431,024 shares, $8.8M, 0.76% of portfolio
- 2022 Q3: 431,024 shares, $11M, 0.87% of portfolio
- 2022 Q4: 431,024 shares, $13M, 1.1% of portfolio
- 2023 Q1: 431,224 shares, $9.4M, 0.78% of portfolio, Add 0.0%
- 2023 Q2: 431,224 shares, $8.8M, 0.71% of portfolio
- 2023 Q3: 431,224 shares, $7.7M, 0.73% of portfolio
- 2023 Q4: 1,373,764 shares, $29M, 2.7% of portfolio, Add +218.6%
- 2024 Q1: 799,906 shares, $18M, 2.0% of portfolio, Reduce −41.8%
- 2024 Q2: 803,641 shares, $20M, 2.3% of portfolio, Add +0.5%
- 2024 Q3: 843,971 shares, $28M, 3.7% of portfolio, Add +5.0%
- 2024 Q4: 843,971 shares, $11M, 1.7% of portfolio
- 2025 Q1: 1,020,713 shares, $19M, 3.6% of portfolio, Add +20.9%
- 2025 Q2: 812,821 shares, $18M, 3.8% of portfolio, Reduce −20.4%
- 2025 Q3: 673,520 shares, $21M, 3.8% of portfolio, Reduce −17.1%
- 2025 Q4: 690,032 shares, $33M, 4.7% of portfolio, Add +2.5%
- 2026 Q1: 638,161 shares, $35M, 5.4% of portfolio, Reduce −7.5%
- 2026 Q2: 603,489 shares, $41M, 5.6% of portfolio, Reduce −5.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|